Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
Study sponsor: Karyopharm Therapeutics Inc · KPTI
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2020-02-18Actual
Enrollment · participants402Actual
Source updated2024-08-21Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.